Predictive factors of thromboembolic complications in patients with esophagogastric adenocarcinoma undergoing preoperative chemotherapy.
dc.contributor.author | Papaxoinis, Georgios | |
dc.contributor.author | Kamposioras, K | |
dc.contributor.author | Germetaki, Theodora | |
dc.contributor.author | Weaver, Jamie M | |
dc.contributor.author | Stamatopoulou, Sofia | |
dc.contributor.author | Nasralla, Magdy | |
dc.contributor.author | Kordatou, Zoe | |
dc.contributor.author | Owen-Holt, Vikki | |
dc.contributor.author | Anthoney, A | |
dc.contributor.author | Mansoor, Was | |
dc.date.accessioned | 2018-02-12T14:11:34Z | |
dc.date.available | 2018-02-12T14:11:34Z | |
dc.date.issued | 2018-01-08 | |
dc.identifier.citation | Predictive factors of thromboembolic complications in patients with esophagogastric adenocarcinoma undergoing preoperative chemotherapy. 2018:1-9 Acta Oncol | en |
dc.identifier.issn | 1651-226X | |
dc.identifier.pmid | 29308947 | |
dc.identifier.doi | 10.1080/0284186X.2017.1423375 | |
dc.identifier.uri | http://hdl.handle.net/10541/620820 | |
dc.description.abstract | Thromboembolic events (TEEs) represent a significant treatment and disease complication for cancer patients. In the present study we assessed the incidence of TEEs in patients receiving preoperative chemotherapy for esophagogastric adenocarcinoma. The risk factors for TEE development and their impact on prognosis were further analyzed. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to Acta oncologica (Stockholm, Sweden) | en |
dc.title | Predictive factors of thromboembolic complications in patients with esophagogastric adenocarcinoma undergoing preoperative chemotherapy. | en |
dc.type | Article | en |
dc.contributor.department | Department of Medical Oncology , The Christie NHS Foundation Trust , Manchester , UK | en |
dc.identifier.journal | Acta Oncologica | en |
html.description.abstract | Thromboembolic events (TEEs) represent a significant treatment and disease complication for cancer patients. In the present study we assessed the incidence of TEEs in patients receiving preoperative chemotherapy for esophagogastric adenocarcinoma. The risk factors for TEE development and their impact on prognosis were further analyzed. |